Results 221 to 230 of about 17,389,371 (292)

Systemic RVX‐208 Attenuates Experimental Periodontitis Through Inflammatory Host Modulation

open access: yesJournal of Periodontal Research, EarlyView.
Prophylactic systemic treatment with RVX‐208 mitigated alveolar bone loss in experimental periodontitis. In THP‐1 cells, transcriptomic analysis showed that RVX‐208 downregulated inflammatory gene expression associated with Pg, and it produced a more moderate and limited effect on global gene expression than the pan‐BET inhibitor JQ1.
Sheikh Alam   +12 more
wiley   +1 more source

A Population Pharmacokinetic Model of Gentamicin in Hospitalized Neonatal Foals

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Information on safe and effective gentamicin dosing in foals is limited. This study aimed to provide guidance regarding optimal dosing regimens by means of a population pharmacokinetic (popPK) model. Gentamicin plasma concentration of 290 samples from 72 hospitalized foals (≤ 14 days old), treated with intravenous (IV) gentamicin, was measured
Astrid J. van den Brom‐Spierenburg   +12 more
wiley   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

open access: yesObesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy